magnolin has been researched along with osteoprotegerin in 1 studies
Studies (magnolin) | Trials (magnolin) | Recent Studies (post-2010) (magnolin) | Studies (osteoprotegerin) | Trials (osteoprotegerin) | Recent Studies (post-2010) (osteoprotegerin) |
---|---|---|---|---|---|
27 | 0 | 19 | 5,108 | 212 | 2,726 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, WY; Jun, AY; Kim, HJ; Lee, DH; Park, KK; Son, KH; Woo, MH | 1 |
1 other study(ies) available for magnolin and osteoprotegerin
Article | Year |
---|---|
Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts.
Topics: Animals; Benzodioxoles; Bone Resorption; Breast Neoplasms; Cell Line, Tumor; Female; Furans; Gene Expression Regulation, Neoplastic; Humans; Lignans; Lignin; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Osteoblasts; Osteoclasts; Osteoprotegerin; Parathyroid Hormone-Related Protein; RANK Ligand; RNA, Messenger | 2014 |